Mon, Nov 04, 2024
Despite this setback, Sun Pharma’s stock has rallied 43 per cent year-to-date, fueled by growth in speciality drugs, emerging markets, and domestic sales.
More >
Mon, Oct 28, 2024
Led by growth in its domestic business, the specialty generic pharma company is expected to post good July-September quarter.
Wed, Sep 11, 2024
Share Market News: The Sensex ended 398.1 points lower at 81,523.2 while the Nifty50 settled at 24,918.5, down 122.7 points from its previous close.
Thu, Dec 08, 2022
The 30-share index gained 160 points to settle at 62,570.68 as 13 of its components advanced while 17 declined.
Sunpharma share price, NSE: SUNPHARMA: Shares of Sun Pharmaceutical Industries Ltd fell more than 3 per cent after United States Food and Drug Administration (USFDA) put its Halol, Gujarat facility under import alert.
Mon, Nov 21, 2022
Indian automotive manufacturer Tata Motors will replace pharmaceutical company Dr Reddy’s Laboratories in the 30-share benchmark S&P BSE Sensex effective December 19, 2022.
Wed, Nov 02, 2022
Except for Nifty Metal, Pharma, and Media almost all sectoral indices closed negative. Nifty Auto, IT and Banks dragged the frontline indices most during today’s session.
Indian equity markets ended on a negative note on Wednesday, breaking a four-day gaining streak. The stock markets traded in a narrow range today after opening in the green only to take a U-turn, minutes later.
Sun Pharma share price: Post second quarter results, brokerages have revised the target price on the stock
Traders Diary: In today's edition of traders diary, Zee Business reserach team brings an exclusive research on 20 stocks where investors could look to make strategies to maximise their gains or avert losses
Mon, Oct 31, 2022
As per Zee Business estimates, the company’s revenue may come at Rs 10,808 crore, and profit after tax at Rs 1.964.7 crore, while EBITDA is likely to be at Rs 2781.7 crore and, margins around 25.7 per cent in Q2.
Mon, Oct 03, 2022
In contrast to the benchmark indices, the pharma and healthcare indices surged in a weak market.
Thu, Sep 29, 2022
The stock in the last two sessions has gained nearly 7% on account of the acquisition announcement of Uractiv portfolio from Fiterman Pharma in Romania
The stock in the last two sessions has gained nearly 7 per cent on account of the acquisition announcement of Uractiv portfolio from Fiterman Pharma in Romania.
Sat, Sep 03, 2022
Stocks to Buy: From pharmaceutical to information and technology, domestic brokerage from Centrum Broking comes out with the top five large-cap company stocks with high conviction to buy in September for an upside of up to 44 per cent on a long-term basis.
Mon, Aug 01, 2022
Despite healthy Q1FY23 earnings, the pharma major Sun Pharma shares were seen trading flat in the early morning and later declined more than 3 per cent to Rs 913 per share on the BSE intraday on Monday.
Mon, Jul 25, 2022
Life Insurance Corporation on Monday said it has reduced shareholding in Sun Pharmaceuticals by selling 2 per cent stake in the company for about Rs 3,882 crore
Fri, Jul 22, 2022
Global Brokerage report on pharma stocks of this week. In this video know the full list and target price to make a buy choice.
Mon, Jun 06, 2022
Drug major Sun Pharma plans to increase its field force in the domestic market by 10 per cent in the current fiscal in order to drive twin objectives of brand focus and geographical expansion, according to a senior company official.
Tue, May 31, 2022
Indian markets on Tuesday witnessed a gap-down opening as Sensex slumped over 300 points and Nifty above 16600 levels. Almost all indices were in red with Nifty IT and FMCG being the top losers.
Sun, May 22, 2022
The drug is used to treat depression and prevent Seasonal Affective Disorder (SAD). It is also used to help people stop smoking.
Thu, Mar 31, 2022
The National Pharma Pricing Authority (NPPA) has approved 10.8% hike in over 800 essential drugs starting April 1,2022. This is the biggest hike by NPPA in the last 10 years.
Tue, Mar 22, 2022
Sun Pharma on Monday said it has entered into a share purchase agreement with Japan's Daiichi Sankyo Company to acquire the latter's 11.28 percent stake in Zenotech Laboratories.
By accepting cookies, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.
